Regulatory

WARD 24/7 > Collaborators > Regulatory

The WARD-project has received grants from the Innovation Fund Denmark, the Novo Nordic Foundation, the Danish Cancer Society, Steno Diabetes Center Denmark, Copenhagen Center for Health Technology, Radiometer, A.P. Møller Foundation as well as internal institutional funding. The WARD founders have created a start-up company, WARD247 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project. WARD247 ApS has obtained license agreement for any WARD-project software and patents. One patent has been filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD) – Clinical Support System (CSS) – an automated clinical support system to improve patient safety and outcomes

 

Please see the regulatory and commercial homepage: WARD247.com